Bell Rock Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bell Rock Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-260	Closed	-$17K	–	93
2019 Q4	$17K	Hold	260	–	–	0.01%	289
2019 Q3	$13K	Buy	260 +1	+0.4%	+$47	0.01%	292
2019 Q2	$12K	Sell	259 -468	-64%	-$21.8K	0.01%	293
2019 Q1	$34K	Sell	727 -924	-56%	-$46K	0.02%	260
2018 Q4	$85K	Sell	1,651 -2,000	-55%	-$107K	0.06%	185
2018 Q3	$227K	Buy	3,651 +1	+0%	+$59	0.11%	118
2018 Q2	$202K	Hold	3,650	–	–	0.1%	129
2018 Q1	$231K	Hold	3,650	–	–	0.12%	116
2017 Q4	$223K	Buy	3,650 +1	+0%	+$63	0.12%	120
2017 Q3	$232K	Buy	3,649 +2,000	+121%	+$117K	0.13%	115
2017 Q2	$92K	Buy	1,649 +1	+0.1%	+$54	0.06%	180
2017 Q1	$90K	Hold	1,648	–	–	0.08%	142
2016 Q4	$96K	Buy	+1,648	New	+$90.1K	0.1%	131

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bell Rock Capital's BMY Position: Q1 2020 in Review

Bell Rock Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 260 shares — an estimated $17K sold.

Bell Rock Capital first reported a position in BMY in Q4 2016 and held it in 13 quarters. The position peaked at $232K in Q3 2017. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

Bell Rock Capital reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
Bell Rock Capital sold 260 Bristol-Myers Squibb shares in Q1 2020, an estimated $17K.
Bell Rock Capital first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 13 quarters.
Bell Rock Capital's Bristol-Myers Squibb position peaked at $232K in Q3 2017.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Bell Rock Capital's 13F filing for Q1 2020, filed 7 May 2020.